Results 251 to 260 of about 25,581,606 (307)
Some of the next articles are maybe not open access.

Non-small-cell lung cancer

The Lancet, 2011
In the decade since the last Lancet Seminar on lung cancer there have been advances in many aspects of the classification, diagnosis, and treatment of non-small-cell lung cancer (NSCLC). An international panel of experts has been brought together to focus on changes in the epidemiology and pathological classification of NSCLC, the role of CT screening ...
Peter, Goldstraw   +6 more
openaire   +3 more sources

Non–Small Cell Lung Cancer

Journal of the National Comprehensive Cancer Network, 2008
Lung cancer is the leading cause of cancer-related death in both men and women in the United States. An estimated 213,380 new cases (114,760 men and 98,620 women) of lung and bronchus cancer will be diagnosed in 2007, and 160,390 deaths (89,510 in men, 70,880 in women) are estimated to occur because of the disease.
David S, Ettinger   +24 more
openaire   +2 more sources

Non-small cell lung cancer

Current Problems in Cancer, 1987
Lung cancer stands as the most important malignant neoplasm in the United States because of its high prevalence, increasing incidence, high rate of mortality, and great potential for prevention through the control of cigarette smoking. The World Health Organization (WHO) classification of lung cancer identifies four major types: squamous cell carcinoma,
C M, Haskell, E C, Holmes
openaire   +3 more sources

Therapy of non-small cell lung cancer [PDF]

open access: possibleLung Cancer, 1995
Several regimes can provide clinical answers and longer survival to patients with small cell carcinoma of the lungs who respond to treatment. Moreover there is frequently also suppression of pathological symptoms of the disease in these patients.
openaire   +3 more sources

Bevacizumab in Non-Small Cell Lung Cancer

Drugs, 2008
Lung cancer continues to be the leading cause of cancer death in Western countries. The median survival time for advanced non-small cell lung cancer (NSCLC) remains poor and chemotherapy is the treatment of choice for most patients with metastatic NSCLC. Platinum-based chemotherapy has long been the standard of care for advanced NSCLC. The formation of
Di Costanzo F.   +6 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy